Correlation Between Vitrolife and Lipum AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and Lipum AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and Lipum AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and Lipum AB, you can compare the effects of market volatilities on Vitrolife and Lipum AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of Lipum AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and Lipum AB.

Diversification Opportunities for Vitrolife and Lipum AB

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vitrolife and Lipum is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and Lipum AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipum AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with Lipum AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipum AB has no effect on the direction of Vitrolife i.e., Vitrolife and Lipum AB go up and down completely randomly.

Pair Corralation between Vitrolife and Lipum AB

Assuming the 90 days trading horizon Vitrolife AB is expected to under-perform the Lipum AB. But the stock apears to be less risky and, when comparing its historical volatility, Vitrolife AB is 1.19 times less risky than Lipum AB. The stock trades about -0.13 of its potential returns per unit of risk. The Lipum AB is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  1,410  in Lipum AB on August 28, 2024 and sell it today you would earn a total of  280.00  from holding Lipum AB or generate 19.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  Lipum AB

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vitrolife is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Lipum AB 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lipum AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Lipum AB unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vitrolife and Lipum AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and Lipum AB

The main advantage of trading using opposite Vitrolife and Lipum AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, Lipum AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipum AB will offset losses from the drop in Lipum AB's long position.
The idea behind Vitrolife AB and Lipum AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume